Using big data in healthcare – e.g. big data in hospitals, clinics, and EMR, – is inciting a transformation in the way that way doctors treat patients.
Providing healthcare providers with access to a full medical history gives a complete picture of an individual’s life, rather than just focusing on the obvious symptoms or relying on partial medical histories. This not only enables the provider to take an integrated, holistic approach to treatments, but creating a portable medical history aids in doctor referral management. Furthermore, since education is essential to taking ownership of health, tailored engagement programs can provide a platform to educate patients through focused instruction.
Big data is changing the current healthcare paradigm from being reactionary healthcare to proactive healthcare – putting the patients first in order to improve the quality of care.
Pharma-clinical-trial-programs have resisted adopting BI due to its inability to satisfy regulations; including security, audit-trails and communication between companies. While not commonly seen in clinical trials, pharma companies have benefited from utilizing BI. For example, Astra Zeneca uses BI to generate immediate responses to report inquiries, while Roch’s Spain Division uses BI to generate and send individualized information to each division. Both companies increased sales since incorporating BI solutions into their decision-making process. Pharma companies can benefit from using BI in clinical trials to create Clinical Research Intelligence frameworks to enhance data collection, analysis, reporting, and dissemination to participants in other locations.
Below are the findings based on a research done to determine the views of senior executives at larger healthcare organizations. The healthcare organizations participated in the research were:
- Denver Health and Hospital Authority
- Lincolnshire Partnership Foundation Trust
- Hartford Hospital
- Hospital for Sick Children in Toronto
- University Health Network